(Q34303356)

1 August 2017

1 reference

title

Role of coenzyme Q10 in chronic heart failure, angina, and hypertension (English)

1 reference

1 August 2017

0 references

1 reference

chronic heart failure

1 reference

Tran MT

1

1 reference

1 August 2017

Mitchell TM

series ordinal

2

1 reference

1 August 2017

Kennedy DT

series ordinal

3

1 reference

1 August 2017

Giles JT

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

21

1 reference

1 August 2017

7

1 reference

1 August 2017

797-806

1 reference

Coenzyme Q10 in health and disease

1 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Deficiency of coenzyme Q10 in hypertensive rats and reduction of deficiency by treatment with coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.797.34564

10.1592/PHCO.21.9.797.34564

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference